Search for another bill
Search for another bill or initiative
SB 5240 - 2025-26
Concerning anaphylaxis medications in schools.
Bill status-at-a-glance
As of Tuesday, January 20, 2026 03:20 AM
Current status:
S3rd Reading
Where is it in the process?
Bill status-at-a-glance
As of Tuesday, January 20, 2026 03:20 AM
Current status:
S3rd Reading
Where is it in the process?
Bill history
2025 Regular Session
In the Senate
Jan 14
First reading, referred to Early Learning & K-12 Education.
(View original bill)
Jan 29
Public hearing in the Senate Committee on Early Learning & K-12 Education at 10:30 AM.
(Committee materials)
Feb 11
Executive action taken in the Senate Committee on Early Learning & K-12 Education at 8:00 AM.
(Committee materials)
EDU - Majority; 1st substitute bill be substituted, do pass.
(View 1st substitute)
(Majority report)
Feb 12
Passed to Rules Committee for second reading.
Mar 5
Placed on second reading by Rules Committee.
Mar 10
1st substitute bill substituted (EDU 25).
(View 1st substitute)
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
(View this roll call)
In the House
Mar 12
First reading, referred to Education.
Mar 18
Public hearing in the House Committee on Education at 4:00 PM.
(Committee materials)
Apr 27
By resolution, returned to Senate Rules Committee for third reading.
2026 Regular Session
In the Senate
Jan 12
By resolution, reintroduced and retained in present status.
Jan 13
Placed on third reading by Rules Committee.
Available documents
For a complete list of documents, go to Detailed Legislative Reports Text of a legislative document.
Fiscal note
Amendments
Available videos